North America Implantable Cardiac Monitors Market By Indication (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained Falls), End User (Hospitals, Cardiac Center & Clinics, Ambulatory Surgical Centers)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The North America Implantable Cardiac Monitors Market would witness market growth of 6.8% CAGR during the forecast period (2018 – 2024).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device. Presently the market is witnessing moderate growth owing to the factors such as technological advancements in cardiac monitor devices such as miniaturization and easier implant procedures, growing demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation. Additionally, growing cases of cardiovascular diseases, remote monitoring systems and growing use of implantable cardiac monitors to monitor epilepsy disorder add to the growth of the market.
Based on Indication, the report is segmented into Cardiac Arrhythmias, Atrial Fibrillation and Epilepsy & Unexplained falls. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery centers (ASCs) and Cardiac Center & Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH ,Schiller AG, Jarvik Heart, Inc.
Scope of the Study
- Cardiac Arrhythmias
- Atrial Fibrillation
- Epilepsy & Unexplained falls
By End User
- Ambulatory Surgery Centers (ASCs)
- Cardiac Center & Clinics
- Rest of North America
- Abiomed, Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Reliant Heart, Inc.
- Astellas Pharma inc.
- Biotronik SE & Co. KG
- Agilent Technologies, Inc.
- Berlin Heart GmbH
- Schiller AG
- Jarvik Heart, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free